Publicacións en colaboración con investigadores/as de Eli Lilly and Company (11)

2020

  1. Complement genes contribute sex-biased vulnerability in diverse disorders

    Nature, Vol. 582, Núm. 7813, pp. 577-581

2019

  1. Gene expression imputation across multiple brain regions provides insights into schizophrenia risk

    Nature Genetics, Vol. 51, Núm. 4, pp. 659-674

  2. Publisher Correction: Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection (Nature Genetics, (2018), 50, 3, (381-389), 10.1038/s41588-018-0059-2)

    Nature Genetics

  3. Publisher Correction: Gene expression imputation across multiple brain regions provides insights into schizophrenia risk (Nature Genetics, (2019), 51, 4, (659-674), 10.1038/s41588-019-0364-4)

    Nature Genetics

2018

  1. Age at first birth in women is genetically associated with increased risk of schizophrenia

    Scientific Reports, Vol. 8, Núm. 1

  2. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection

    Nature Genetics, Vol. 50, Núm. 3, pp. 381-389

2017

  1. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects

    Nature Genetics, Vol. 49, Núm. 1, pp. 27-35

  2. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia

    Nature Communications, Vol. 8

2016

  1. Genetic influences on schizophrenia and subcortical brain volumes: Large-scale proof of concept

    Nature Neuroscience, Vol. 19, Núm. 3, pp. 420-431

2015

  1. LD score regression distinguishes confounding from polygenicity in genome-wide association studies

    Nature Genetics, Vol. 47, Núm. 3, pp. 291-295

2014

  1. Biological insights from 108 schizophrenia-associated genetic loci

    Nature, Vol. 511, Núm. 7510, pp. 421-427